Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 2, 2004, Pages 239-244

  Cheng, Tzu Hurng ^a,b,c   Liu, Ju Chi ^a   Lin, Heng ^b   Shih, Neng Lang ^b   Chen, Yen Ling ^b   Huang, Meng Ting ^b   Chan, Paul ^a   Cheng, Ching Feng ^b   Chen, Jin Jer ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Myosin heavy chain; Angiotensin II; Cardiomyocyte hypertrophy; Extracellular signal regulated kinase; Reactive oxygen species; Resveratrol

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN; DICHLOROFLUORESCEIN; FLUORESCENT DYE; HYDROGEN PEROXIDE; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYOSIN HEAVY CHAIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRITIUM;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; MUSCLE HYPERTROPHY; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN SYNTHESIS; RAT; WESTERN BLOTTING;

ACETYLCYSTEINE; ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CELLS, CULTURED; HYPERTROPHY; LEUCINE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STILBENES; TRANSFECTION; VENTRICULAR MYOSINS;

EID: 1442276364     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0849-6     Document Type: Article

References (34)

1. Bastianetto S, Zheng WH, Quirion R (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 131:711-720
2. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A (1998) Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res 24:51-55
3. Cheng TH, Shih NL, Chen SY, Wang DL, Chen JJ (1999) Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 41:654-662
4. Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, Liu SH, Wang DL, Chen JJ (2001) Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/ Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 33:1805-1814
5. Das DK, Sato M, Ray PS, Maulik G, Engelman RM, Bertelli AA, Bertelli A (1999) Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 25:115-120
6. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
7. German JB, Walzem RL (2000) The health benefits of wine. Annu Rev Nutr 20:561-593
8. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM (2002) Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 62:772-777
9. Hattori R, Otani H, Maulik N, Das DK (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol 282:H1988-H1995
10. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M (2002) Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515
11. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK (2002) The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 135:1627-1633
12. Jang JH, Surh YJ (2001) Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat Res 496:181-190
13. Lefer DJ, Granger DN (2000) Oxidative stress and cardiac disease. Am J Med 109:315-323
14. Martinez J, Moreno JJ (2000) Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59:865-870
15. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, Rimm EB (2003) Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348:109-118
16. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794-799
17. Olas B, Wachowicz B (2002) Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 106:143-148
18. Olas B, Zbikowska HM, Wachowicz B, Krajewski T, Buczynski A, Magnuszewska A (1999) Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol 46:961-966
19. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61:294-302
20. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 27:160-169
21. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S (2001) ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661-669
22. Sato M, Maulik N, Das DK (2002) Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann N Y Acad Sci 957:122-135
23. Shih NL, Cheng TH, Loh SH, Cheng PY, Wang DL, Chen YS, Liu SH, Liew CC, Chen JJ (2001) Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes. Biochem Biophys Res Commun 283:143-148
24. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586-22594
25. Sun AY, Simonyi A, Sun GY (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32:314-318
26. Tanaka K, Honda M, Takabatake T (2001) Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 37:676-685
27. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, Hannan RD (2002) Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 90:135-142
28. Van Wamel AJ, Ruwhof C, van der Valk-Kokshoom LE, Schrier PI, van der Laarse A (2001) The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy. Mol Cell Biochem 218:113-124
29. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-1658
30. Wang DL, Chen JJ, Shin NL, Kao YC, Hsu KH, Huang WY, Liew CC (1992) Endothelin stimulates cardiac alpha-and beta-myosin heavy chain gene expression. Biochem Biophys Res Commun 183:1260-1265
31. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM (2002) Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 9:77-79
32. Wollert KC, Drexler H (1999) The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43:838-849
33. Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H (2002) Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 39:87-92
34. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH (2000) Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 275:37895-37901